Cargando…

Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer

BACKGROUND: Tumor deposits (TDs) are not equivalent to lymph node (LN) metastasis (LNM) but have become independent adverse prognostic factors in patients with rectal cancer (RC). Although preoperatively differentiating TDs and LNMs is helpful in designing individualized treatment strategies and ach...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong-Chang, Li, Mou, Jin, Yu-Mei, Xu, Jing-Xu, Huang, Chen-Cui, Song, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367222/
https://www.ncbi.nlm.nih.gov/pubmed/36157536
http://dx.doi.org/10.3748/wjg.v28.i29.3960
_version_ 1784765739646844928
author Zhang, Yong-Chang
Li, Mou
Jin, Yu-Mei
Xu, Jing-Xu
Huang, Chen-Cui
Song, Bin
author_facet Zhang, Yong-Chang
Li, Mou
Jin, Yu-Mei
Xu, Jing-Xu
Huang, Chen-Cui
Song, Bin
author_sort Zhang, Yong-Chang
collection PubMed
description BACKGROUND: Tumor deposits (TDs) are not equivalent to lymph node (LN) metastasis (LNM) but have become independent adverse prognostic factors in patients with rectal cancer (RC). Although preoperatively differentiating TDs and LNMs is helpful in designing individualized treatment strategies and achieving improved prognoses, it is a challenging task. AIM: To establish a computed tomography (CT)-based radiomics model for preoperatively differentiating TDs from LNM in patients with RC. METHODS: This study retrospectively enrolled 219 patients with RC [TDs(+)LNM(- )(n = 89); LNM(+) TDs(- )(n = 115); TDs(+)LNM(+ )(n = 15)] from a single center between September 2016 and September 2021. Single-positive patients (i.e., TDs(+)LNM(-) and LNM(+)TDs(-)) were classified into the training (n = 163) and validation (n = 41) sets. We extracted numerous features from the enhanced CT (region 1: The main tumor; region 2: The largest peritumoral nodule). After deleting redundant features, three feature selection methods and three machine learning methods were used to select the best-performing classifier as the radiomics model (Rad-score). After validating Rad-score, its performance was further evaluated in the field of diagnosing double-positive patients (i.e., TDs(+)LNM(+)) by outlining all peritumoral nodules with diameter (short-axis) > 3 mm. RESULTS: Rad-score 1 (radiomics signature of the main tumor) had an area under the curve (AUC) of 0.768 on the training dataset and 0.700 on the validation dataset. Rad-score 2 (radiomics signature of the largest peritumoral nodule) had a higher AUC (training set: 0.940; validation set: 0.918) than Rad-score 1. Clinical factors, including age, gender, location of RC, tumor markers, and radiological features of the largest peritumoral nodule, were excluded by logistic regression. Thus, the combined model was comprised of Rad-scores of 1 and 2. Considering that the combined model had similar AUCs with Rad-score 2 (P = 0.134 in the training set and 0.594 in the validation set), Rad-score 2 was used as the final model. For the diagnosis of double-positive patients in the mixed group [TDs(+)LNM(+ )(n = 15); single-positive (n = 15)], Rad-score 2 demonstrated moderate performance (sensitivity, 73.3%; specificity, 66.6%; and accuracy, 70.0%). CONCLUSION: Radiomics analysis based on the largest peritumoral nodule can be helpful in preoperatively differentiating between TDs and LNM.
format Online
Article
Text
id pubmed-9367222
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-93672222022-09-23 Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer Zhang, Yong-Chang Li, Mou Jin, Yu-Mei Xu, Jing-Xu Huang, Chen-Cui Song, Bin World J Gastroenterol Retrospective Study BACKGROUND: Tumor deposits (TDs) are not equivalent to lymph node (LN) metastasis (LNM) but have become independent adverse prognostic factors in patients with rectal cancer (RC). Although preoperatively differentiating TDs and LNMs is helpful in designing individualized treatment strategies and achieving improved prognoses, it is a challenging task. AIM: To establish a computed tomography (CT)-based radiomics model for preoperatively differentiating TDs from LNM in patients with RC. METHODS: This study retrospectively enrolled 219 patients with RC [TDs(+)LNM(- )(n = 89); LNM(+) TDs(- )(n = 115); TDs(+)LNM(+ )(n = 15)] from a single center between September 2016 and September 2021. Single-positive patients (i.e., TDs(+)LNM(-) and LNM(+)TDs(-)) were classified into the training (n = 163) and validation (n = 41) sets. We extracted numerous features from the enhanced CT (region 1: The main tumor; region 2: The largest peritumoral nodule). After deleting redundant features, three feature selection methods and three machine learning methods were used to select the best-performing classifier as the radiomics model (Rad-score). After validating Rad-score, its performance was further evaluated in the field of diagnosing double-positive patients (i.e., TDs(+)LNM(+)) by outlining all peritumoral nodules with diameter (short-axis) > 3 mm. RESULTS: Rad-score 1 (radiomics signature of the main tumor) had an area under the curve (AUC) of 0.768 on the training dataset and 0.700 on the validation dataset. Rad-score 2 (radiomics signature of the largest peritumoral nodule) had a higher AUC (training set: 0.940; validation set: 0.918) than Rad-score 1. Clinical factors, including age, gender, location of RC, tumor markers, and radiological features of the largest peritumoral nodule, were excluded by logistic regression. Thus, the combined model was comprised of Rad-scores of 1 and 2. Considering that the combined model had similar AUCs with Rad-score 2 (P = 0.134 in the training set and 0.594 in the validation set), Rad-score 2 was used as the final model. For the diagnosis of double-positive patients in the mixed group [TDs(+)LNM(+ )(n = 15); single-positive (n = 15)], Rad-score 2 demonstrated moderate performance (sensitivity, 73.3%; specificity, 66.6%; and accuracy, 70.0%). CONCLUSION: Radiomics analysis based on the largest peritumoral nodule can be helpful in preoperatively differentiating between TDs and LNM. Baishideng Publishing Group Inc 2022-08-07 2022-08-07 /pmc/articles/PMC9367222/ /pubmed/36157536 http://dx.doi.org/10.3748/wjg.v28.i29.3960 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Study
Zhang, Yong-Chang
Li, Mou
Jin, Yu-Mei
Xu, Jing-Xu
Huang, Chen-Cui
Song, Bin
Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title_full Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title_fullStr Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title_full_unstemmed Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title_short Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
title_sort radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367222/
https://www.ncbi.nlm.nih.gov/pubmed/36157536
http://dx.doi.org/10.3748/wjg.v28.i29.3960
work_keys_str_mv AT zhangyongchang radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer
AT limou radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer
AT jinyumei radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer
AT xujingxu radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer
AT huangchencui radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer
AT songbin radiomicsfordifferentiatingtumordepositsfromlymphnodemetastasisinrectalcancer